Efficacy and safety of nanoliposomal irinotecan plus fluorouracil and folinic acid after irinotecan-based chemotherapy in patients with advanced pancreatic cancer: Results of the retrospective part of the NAPOLEON-2 study.

被引：0

作者：

Kawaguchi, Yasunori

Aikawa, Tomomi

Shimokawa, Mototsugu

Otsuka, Taiga

Shibuki, Taro

Nakazawa, Junichi

Arima, Shiho

Miwa, Keisuke

Koga, Futa

Ueda, Yujiro

Kubotsu, Yoshihito

Shimokawa, Hozumi

Takeshita, Shigeyuki

Nishikawa, Kazuo

Hosokawa, Ayumu

Oda, Hisanobu

Sakai, Tatsunori

Shirakawa, Tsuyoshi

Mizuta, Toshihiko

Mitsugi, Kenji

机构：

[1] Asakura Med Assoc Hosp, Asakura, Japan

[2] Japan Community Healthcare Org Kyushu Hosp, Kitakyushu, Fukuoka, Japan

[3] Yamaguchi Univ, Grad Sch Med, Dept Biostat, Yamaguchi, Japan

[4] Minato Med Clin, Fukuoka, Japan

[5] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[6] Kagoshima City Hosp, Kagoshima, Japan

[7] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima, Japan

[8] Kurume Univ Hosp, Kurume, Fukuoka, Japan

[9] Saga Med Ctr Koseikan, Saga, Japan

[10] Japanese Red Cross Kumamoto Hosp, Kumamoto, Japan

[11] Karatsu Red Cross Hosp, Karatsu, Japan

[12] Japanese Red Cross Nagasaki Genbaku Hosp, Nagasaki, Japan

[13] Oita Univ, Fac Med, Yufu, Japan

[14] Univ Miyazaki Hosp, Dept Clin Oncol, Miyazaki, Japan

[15] Saiseikai Kumamoto Hosp, Kumamoto, Japan

[16] Natl Hosp Org Kumamoto Med Ctr, Kumamoto, Japan

[17] Karatsu Higashimatsuura Med Assoc Ctr, Karatsu, Japan

[18] Fujikawa Hosp, Saga, Japan

[19] Sasebo Kyosai Hosp, Sasebo, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

705

引用

页码：705 / 705

页数：1

共 50 条

[31] PROSPECTIVE TRIAL OF CETUXIMAB PLUS IRINOTECAN FOR OXALIPLATIN AND IRINOTECAN-BASED CHEMOTHERAPY-REFRACTORY PATIENTS ADVANCED AND/OR METASTATIC COLORECTAL CANCER, EVALUATION OF THE EFFICACY AND SAFETY BASED ON MUTATION STATUS OF THE EGFR RELATED GENES [J].

Shimodaira, H. ;

Soeda, H. ;

Gamoh, M. ;

Andoh, H. ;

Yamaguchi, T. ;

Watanabe, M. ;

Ishobe, H. ;

Sudo, T. ;

Kato, S. ;

Ishioka, C. .

ANNALS OF ONCOLOGY, 2012, 23 :119-119

[32] A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy [J].

Grierson, Patrick M. ;

Suresh, Rama ;

Tan, Benjamin ;

Pedersen, Katrina S. ;

Amin, Manik ;

Park, Haeseong ;

Trikalinos, Nikolaos A. ;

Liu, Jingxia ;

Boice, Nicholas ;

Brown, Amberly ;

Bansod, Sapana ;

Wang-Gillam, Andrea ;

Lim, Kian-Huat .

CLINICAL CANCER RESEARCH, 2023, 29 (23) :4733-4739

[33] Phase II Trial of Cetuxirnab plus Irinotecan for Oxaliplatin- and Irinotecan-Based Chemotherapy-Refractory Patients with Advanced and/or Metastatic Colorectal Cancer: Evaluation of Efficacy and Safety Based on KRAS Mutation Status (T-CORE0801) [J].

Soeda, Hiroshi ;

Shimodaira, Hideki ;

Gamoh, Makio ;

Ando, Hideaki ;

Isobe, Hideki ;

Suto, Takeshi ;

Takahashi, Shin ;

Kakudo, Yuichi ;

Amagai, Kenji ;

Mori, Takahiro ;

Watanabe, Mika ;

Yamaguchi, Takuhiro ;

Kato, Shunsuke ;

Ishioka, Chikashi .

ONCOLOGY, 2014, 87 (01) :7-20

[34] Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group [J].

Yoo, Changhoon ;

Im, Hyeon-Su ;

Kim, Kyu-pyo ;

Oh, Do-Youn ;

Lee, Kyung-Hun ;

Chon, Hong Jae ;

Kim, Joo Hoon ;

Kang, Myoungjoo ;

Kim, Ilhwan ;

Lee, Guk Jin ;

Oh, Sung Yong ;

Choi, Younak ;

Choi, Hye Jin ;

Kim, Seung Tae ;

Park, Joon Oh ;

Ryoo, Baek-Yeol .

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11

[35] Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study) [J].

Muro, Kei ;

Boku, Narikazu ;

Shimada, Yasuhiro ;

Tsuji, Akihito ;

Sameshima, Shinichi ;

Baba, Hideo ;

Satoh, Taroh ;

Denda, Tadamichi ;

Ina, Kenji ;

Nishina, Tomohiro ;

Yamaguchi, Kensei ;

Takiuchi, Hiroya ;

Esaki, Taito ;

Tokunaga, Shinya ;

Kuwano, Hiroyuki ;

Komatsu, Yoshito ;

Watanabe, Masahiko ;

Hyodo, Ichinosuke ;

Morita, Satoshi ;

Sugihara, Kenichi .

LANCET ONCOLOGY, 2010, 11 (09) :853-860

[36] Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial [J].

Wang-Gillam, Andrea ;

Li, Chung-Pin ;

Bodoky, Gyoergy ;

Dean, Andrew ;

Shan, Yan-Shen ;

Jameson, Gayle ;

Macarulla, Teresa ;

Lee, Kyung-Hun ;

Cunningham, David ;

Blanc, Jean F. ;

Hubner, Richard A. ;

Chiu, Chang-Fang ;

Schwartsmann, Gilberto ;

Siveke, Jens T. ;

Braiteh, Fadi ;

Moyo, Victor ;

Belanger, Bruce ;

Dhindsa, Navreet ;

Bayever, Eliel ;

Von Hoff, Daniel D. ;

Chen, Li-Tzong .

LANCET, 2016, 387 (10018) :545-557

[37] A phase I/II study of nanoliposomal irinotecan plus S-1 in metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy [J].

Imaoka, H. ;

Sasaki, M. ;

Ueno, M. ;

Ozaka, M. ;

Kobayashi, S. ;

Fukushima, T. ;

Furukawa, T. ;

Ikeda, M. .

ANNALS OF ONCOLOGY, 2022, 33 :S1484-S1484

[38] Irinotecan, oxaliplatin plus bolus 5-fluorouracil and low dose folinic acid every 2 weeks - A feasibility study in metastatic colorectol cancer patients [J].

Martinez, J ;

Martin, C ;

Chacon, M ;

Korbenfeld, E ;

Bella, S ;

Senna, S ;

Richardet, E ;

Coppola, F ;

Bas, C ;

Hidalgo, J ;

Escobar, E ;

Reale, M ;

Smilovich, AM ;

Wasserman, E .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (01) :45-51

[39] Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG) [J].

Park, H. S. ;

Kang, B. ;

Chon, H. J. ;

Im, H-S ;

Lee, C-K ;

Kim, I ;

Kang, M. J. ;

Hwang, J. E. ;

Bae, W. K. ;

Cheon, J. ;

Park, J. O. ;

Hong, J. Y. ;

Kang, J. H. ;

Kim, J. H. ;

Lim, S. H. ;

Kim, J. W. ;

Kim, J-W ;

Yoo, C. ;

Choi, H. J. .

ESMO OPEN, 2021, 6 (02)

[40] SAFETY AND EFFICACY OF IMPRIME PGG PLUS CETUXIMAB WITH IRINOTECAN AND WITHOUT IRINOTECAN IN PATIENTS WITH ADVANCED COLORECTAL CANCER (CRC): A PHASE 1B/2 STUDY WITH KRAS SUBPOPULATION ANALYSIS [J].

Tamayo, M. ;

Cornelio, G. ;

Bautista, J. ;

Flores, M. ;

Tioleco, P. ;

Kurman, M. ;

Vasilakos, J. ;

Marsh, L. ;

Gargano, M. ;

Patchen, M. .

ANNALS OF ONCOLOGY, 2010, 21 :22-23

← 1 2 3 4 5 →